No Covaxin for 18-44 age group from today in Delhi; limited stock for 45+

Topics Coronavirus Vaccine | Delhi | AAP

No centre in the national capital will be able to administer COVID-19 vaccine 'Covaxin' to the age group of 18-44 years due to unavailability of its stock, said Aam Aadmi Party (AAP) MLA Atishi Marlena on Wednesday.

"Despite the number of vaccination centres being increased extensively, the stock for Covaxin is absolutely finished, and due to this, nearly 100 centres administering Covaxin have been forced to temporarily shut down. So, from Thursday, Delhi will not be able to administer Covaxin to the 18-44 age group, due to the shortage of vaccines. Bharat Biotech has refused to deliver any additional doses of Covaxin to Delhi," Atishi said.

"We are hoping that the Central government intervenes in the matter and supplies sufficient Covaxin vials to Delhi. In the next few days, those who have got their first doses will be ready for the second dose," she added.

The AAP MLA informed that for those above 45 years and healthcare/frontline workers, Covaxin's stock is left only for four days and Covishield's stock for three days. Meanwhile, for Covishield, nine days' stock left for those between the 18-44 age group.

Atishi said Delhi received a total of 43,20,490 doses of COVID vaccines for those above 45 years and healthcare/frontline workers till date. Out of these, 40,00,970 doses have already been used and 3,19,520 doses are left for this category.

The AAP MLA further explained that Delhi received only 1.5 lakh doses for Covaxin and 6,67,690 doses of Covishield for the age group of 18-44 years. For this, a fresh consignment arrived on Tuesday evening, which had 2,67,690 doses of Covishield for those between 18-44 years of age. With this, the total number of vaccines received for the 18-44 age group now has increased to 8,17,000. Out of these, 3,82,000 vaccine doses have been utilised and 4,35,000 vials are left for the vaccination drive of next few days.

"We are sincerely hoping that the Centre will make sufficient doses available both for Covaxin and Covishield in the next few days. Delhi has probably faced the most COVID induced hardships ever since the start of the pandemic. Hence, I reiterate that we are hoping that the Central government supplies enough vaccines for the people of Delhi at the earliest," stated Atishi.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel